Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation.
Cataract
endothelial cells
phakic intraocular lenses
postoperative complications
visual acuity
Journal
Beyoglu eye journal
ISSN: 2587-0394
Titre abrégé: Beyoglu Eye J
Pays: Turkey
ID NLM: 101777848
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
02
2019
accepted:
20
02
2019
entrez:
21
2
2022
pubmed:
26
2
2019
medline:
26
2
2019
Statut:
epublish
Résumé
This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland). IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded. The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32±1.09 in the first year and 1.39±1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69±1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was -4.51±9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794). The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.
Identifiants
pubmed: 35187426
doi: 10.14744/bej.2019.52824
pii: BEJ-4-17
pmc: PMC8842041
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17-22Informations de copyright
Copyright: © 2019 by Beyoglu Eye Training and Research Hospital.
Déclaration de conflit d'intérêts
Conflict of Interest: None declared.
Références
Ophthalmology. 2004 Sep;111(9):1683-92
pubmed: 15350323
Korean J Ophthalmol. 2006 Jun;20(2):87-92
pubmed: 16892643
Clin Exp Ophthalmol. 2016 Aug;44(6):481-7
pubmed: 26661832
J Cataract Refract Surg. 2017 Sep;43(9):1163-1170
pubmed: 28991612
J Refract Surg. 2015 Aug;31(8):548-56
pubmed: 26248348
J Cataract Refract Surg. 2014 Dec;40(12):2019-24
pubmed: 25447196
Semin Ophthalmol. 2017;32(6):725-733
pubmed: 27487324
Int J Ophthalmol. 2013 Jun 18;6(3):362-9
pubmed: 23826534
Ophthalmology. 2008 Mar;115(3):464-472.e1
pubmed: 18031820
J Cataract Refract Surg. 2013 Jul;39(7):1023-8
pubmed: 23664355
J Ophthalmol. 2018 Oct 21;2018:5893126
pubmed: 30420916
J Cataract Refract Surg. 2010 Nov;36(11):1976-93
pubmed: 21029908
J Cataract Refract Surg. 2010 Dec;36(12):2168-94
pubmed: 21111322
J Refract Surg. 2011 Nov;27(11):787-91
pubmed: 21739931
Ophthalmology. 2009 Apr;116(4):671-7
pubmed: 19344820
Clin Ophthalmol. 2018 Oct 11;12:2015-2029
pubmed: 30349185
J Cataract Refract Surg. 2011 May;37(5):873-80
pubmed: 21511154
JAMA Ophthalmol. 2016 May 1;134(5):487-494
pubmed: 26941076
Semin Ophthalmol. 2016;31(3):280-4
pubmed: 25412329
J Cataract Refract Surg. 2011 Oct;37(10):1791-8
pubmed: 21930045